InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Hardy Reginald l, Président. Director active across 2 companies, notably Brickell Biotech, Inc.. Aggregated, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €56k. Activity tracked since 23 July 2021. The latest transaction was filed on 31 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hardy Reginald l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
15,180 股@ US$0.22895.2% 占其流量Common StockSEC:0000819050-22-000005:0
100,000 股@ US$0.662394.8% 占其流量Common StockSEC:0000819050-21-000125:0
标准退出：2021年10月21日 (T+90)
2 条申报中的 2 条
About Hardy Reginald l
Reginald L. Hardy is the Chairman of the Board of Brickell Biotech, Inc. He oversees the activities of the board and plays a key role in defining the company's strategy. His experience in the biopharmaceutical sector is an asset in guiding Brickell Biotech towards its objectives.
